Entrectinib in NTRK fusion-positive (NTRK-fp) breast cancer: Updated data from STARTRK-2

Lu, J; Blakely, CM; Barve, M; Chung, CH; Waqar, SN; Hu, X; Delord, JP; Krzakowski, MJ; Yonemori, K; Chen, DT; Klingbiel, D; Heinzmann, S; Le Tourneau, C

ANNALS OF ONCOLOGY, 2022; 33 (): S204